Appropriate use of antibiotics: the role of CAM treatment strategies


Research Network: 2017-01-01 - 2017-12-31
Total sum awarded: €44 220

Worldwide strategies to control antibiotic resistance and its consequences (mortality, costs) are being developed, but are currently insufficiently, as for example demonstrated in the unchanged European consumption rates of antibiotics during the last years (RAND, 2016). Preliminary studies have shown dat Complementary and Alternative Medicine (CAM) practices and hospitals have lower antibiotic prescription rates and lower resistance rates compared to conventional practices based on additional prevention and treatment of infections strategies. In order to offer conventional physicians a safe and effective alternative to antibiotics and to reduce misprescribing and overprescribing of antibiotics broadly, the available practical expertise and scientific knowledge on CAM strategies must be explored and systemized. The working group will collect available information on the use of CAM strategies regarding the use and prescription of alternatives to antibiotics in The Netherlands, France, Germany, England and Switzerland. The Working Group will further focus on the development of an evidence and expertise based decision-making tool for (conventional) doctors and the implementation of this tool in the European countries.

Read More
Read Less
  • Erik W. Baars, University of Applied Sciences Leiden, Netherlands (Coordinator)
  • Willem van Leeuwen, University of Applied Sciences Leiden, Netherlands (Observer)
  • Thomas Breitkreuz, Hufelandgesellschaft, Germany (Observer)
  • Roman Huber, University of Freiberg, Germany (Observer)
  • David Martin, University of Tübingen, Germany (Observer)
  • Harald Matthes, Charité University Medicine, Germany (Observer)
  • Jan Vagedes, ARCIM Institute, Germany (Observer)
  • George Lewith, University of Southampton, United Kingdom (Observer)
  • Esther Van der Werf-Kok, University of Bristol, United Kingdom (Observer)